Publications by authors named "Yoshiaki Fujimura"

Claim this Profile
N
Negative Impact of Coronavirus Disease 2019 Pandemic on Gastric Cancer Care in Japan: A Tokushukai Real-World Data Project 08 (TREAD 08).
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Masataka Taguri, Yoshiaki Fujimura

JGH Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.
Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura

Jpn J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation‑based prognostic markers in patients with advanced or recurrent gastric cancer treated with nivolumab: Tokushukai REAl‑world Data project 02 (TREAD 02).
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Megu Ohtaki, Yoshiaki Fujimura

Mol Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of thromboembolism and prognosis in metastatic pancreatic cancer from the Tokushukai REAl‑world data project.
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Megu Ohtaki, Yoshiaki Fujimura

Mol Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.
Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura

Cancer Chemother Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's Response to Letter to the Editor: "A Deep Dive into Japan's State of Emergency: How Political Decisions Affected Post-COVID-19 Syndrome".
Yasuha Kinugasa, Mara Anais Llamas-Covarrubias, Katsuhiko Ozaki, Yoshiaki Fujimura, Takeki Ohashi

JMA J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).
Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura

Jpn J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation‑based prognostic markers of metastatic pancreatic cancer using real‑world data in Japan: The Tokushukai REAl‑world Data (TREAD) project.
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Megumi Shiragami, Yoshiaki Fujimura

Oncol Lett· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04).
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Masataka Taguri, Yoshiaki Fujimura

Jpn J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project.
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Yoshiaki Fujimura

Mol Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NET in Japan.
Maki Komamine, Yoshiaki Fujimura, Masatomo Omiya, Tosiya Sato

BMC Med Inform Decis Mak· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Coronavirus Disease 2019 Syndrome in Japan: An Observational Study Using a Medical Database.
Yasuha Kinugasa, Mara Anais Llamas-Covarrubias, Katsuhiko Ozaki, Yoshiaki Fujimura, Takeki Ohashi

JMA J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study.
Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Yoshiaki Fujimura

Healthcare (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of hospital differences in missing of clinical laboratory test results in a multi-hospital observational database contributing to MID-NET® in Japan.
Maki Komamine, Yoshiaki Fujimura, Yasuharu Nitta, Masatomo Omiya, Masaaki Doi

BMC Med Inform Decis Mak· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The validity of the claims-based definition of rheumatoid arthritis evaluated in 64 hospitals in Japan.
Kiyoshi Kubota, Masaki Yoshizawa, Satoru Takahashi, Yoshiaki Fujimura, Hiroko Nomura

BMC Musculoskelet Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of the MID-NET medical information database network as a reliable and valuable database for drug safety assessments in Japan.
Mitsune Yamaguchi, Satomi Inomata, Sayoko Harada, Yu Matsuzaki, Maiko Kawaguchi, Yoshiaki Fujimura

Pharmacoepidemiol Drug Saf· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utilization and challenges of Japan's MID-NET medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.
Kaori Yamada, Maori Itoh, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata

Pharmacoepidemiol Drug Saf· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis